Custom oligo synthesis with high specificity, high stability, and low toxicity Custom LNA and BNATM oligonucleotides synthesis service
Date:June 22 2026Web Page No:520120

LNA (Locked Nucleic Acid) and BNATM (Bridged Nucleic Acid) are types of oligonucleotides that have a crosslinking structure in the nucleic acid molecules, which provide excellent stability and specificity for complementary strands. Oligonucleotides with the artificial nucleic acids are ideal tools for detection of small RNA targets, highly similar DNA and RNA targets, and so on.
This custom service offers various scales of DNA/RNA oligonucleotide synthesis using LNA (2', 4'-Bridged Nucleic Acid, 2', 4'-BNATM) with various modifications.
In addition, BNATMsNC which is known to provide high stability and high specificity to complementary strands are also available.
Upon request, in vivo grade is available by filter sterilization and lyophilization under sterile condition.
* The service is provided by GeneDesign, Inc., a part of Ajinomoto Bio-Pharma Services.
* Click here for ordering information.
* The service is for research use only.
- About BNATM oligonucelotides
- What are BNATM and LNA oligonucleotides?
- Features of LNA (2', 4'-BNATM) and BNATM
- Application examples of LNA (2', 4'-BNATM)
- Nuclease resistance of LNA (2', 4'-BNATM) oligonucleotides
- Advantages of in vivo use of LNA (2', 4'-BNATM) oligonucleotides
- Characteristics Table of LNA and BNATM NC
- Reference
- How to order
About BNATM oligonucelotides
BNATM oligonucleotides are manufactured by Ajinomoto Bio-Pharma Services’ GeneDesign facility in Japan for R&D purposes based on a license agreement with RIKEN GENESIS Co., Ltd., in Japan.
Structure of BNATMs

* Available BNATMs for this service
LNA (2', 4'-BNATM) : A, G, T, mC (Methylcytosine)
BNATM NC : T, mC (Methylcytosine)
What are BNATM and LNA oligonucleotides?
BNATM is an abbreviated name of Bridged Nucleic Acid and was developed by Dr. Takeshi Imanishi (Professor, Faculty of Pharmaceutical Sciences, Osaka University). Around 10 types of BNATMs have been developed in the past and the individual BNATMs have different properties such as binding affinity (hybridization ability), and nuclease resistance.

Figure 1 Basic structures of BNATMs
Features of LNA (2', 4'-BNATM) and BNATM
- LNA and BNATM have extensively high binding affinity to DNA and RNA because of the fixed N-type structure of it.
- Oligonucleotides with partial insertion of LNA or BNATM have superior nuclease resistance compared with natural oligonucleotides.
- Various modifications such as terminal modification, and phosphorothioate formation are compatible.
- There have been studies suggesting that LNA oligomers have higher safety when compared to S-oligos (Phosphorothioate oligonucleotides) for in vivo studying.
Application examples of LNA (2', 4'-BNATM)
- Antisense oligonucleotides instead of S-oligonucleotides1
- Application to siRNA
- Functional inhibition of miRNA2
- in situ hybridization probe etc.
Nuclease resistance of LNA (2', 4'-BNATM) oligonucleotides
It is suggested that LNA (2', 4'-BNATM) oligonucleotides have improved stability in animals because oligonucleotides with partial insertion of LNA have superior nuclease resistance compared with natural oligonucleotides. In experiments using animal cells and/or laboratory animals, even if a small amount of LNA oligos is expected to produce long-lasting effects such as antisense and siRNA.
Advantages of in vivo use of LNA (2', 4'-BNATM) oligonucleotides
There have been studies suggesting that LNA oligomers have higher safety when compared to S-oligos. LNA oligomers are conventionally used for antisense oligonucleotides in in vivo experiments. It was reported that rats injected with S-oligo in the brain showed a clear exothermic reaction, and nerve cell dropouts were observed in the brain histopathology of this rat. On the other hand, for rats injected with LNA-oligo, such pathological findings are not seen. As a result, LNA-oligo can be regarded as safer in vivo than S-oligo1.
Characteristics Table of LNA and BNATM NC
| LNA(2', 4'-BNATM) | BNATM NC | BNATM NC(Me) | |
| Binding Capacity | ◎ | ◎ | ◎ |
| Enzyme Resistance | ● | ◎ | ◎ |
Advantage: ◎ > ○ > ● > Natural nucleic acid

* Additional information of BNATM and LNA below is available. Click here!
- High binding affinity
- High nuclease resistance
- Toxicity study example
Reference
- Wahlestedt, C., et al., Proc. Natl. Acad. Sci. USA, 97, 5633~5638 (2000).
- Corsten, M. F., et al., Cancer Res., 67, 8994~9000 (2007).
- Obernosterer, G., et al., Nat. Protoc., 2, 1508~1514 (2007).
- Mitsuoka、Y.、et al., Nucleic Acids Res., 37, 1225~1238 (2009).
- Abdur Rahman、S. M., et al., J. Am. Chem. Soc., 130, 4886~4896 (2008).
How to order
Please download the Excel file of Quotation Request Sheet, fill out the form including oligo sequences and other required information, and send the file to your local distributor. We only accept the Excel file; we do not accept PDF or FAX. After reviewed by GeneDesign, we will send a quote via your local dealer.
* A, G, T, mC (methylated cytosine) can be supplied in LNA (2', 4'-BNATM). U and C are not available.
* Delivery amount is estimated by absorption spectrometry.
CONTACT
export@funakoshi.co.jp
- ※Prices on our website are for your reference only. Please inquire your distributor for your prices.
- ※Please note that Product Information or Price may change without notice.